![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 5/00 | (2006.01) |
(11) | Number of the document | 2976422 |
(13) | Kind of document | T |
(96) | European patent application number | 14717171.4 |
Date of filing the European patent application | 2014-03-18 | |
(97) | Date of publication of the European application | 2016-01-27 |
(45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
(46) | Date of publication of the claims translation | 2018-04-25 |
(86) | Number | PCT/GB2014/050850 |
Date | 2014-03-18 |
(87) | Number | WO 2014/147386 |
Date | 2014-09-25 |
(30) | Number | Date | Country code |
201304973 | 2013-03-19 | GB |
(72) |
MCVEY, John Henderson, GB
GARNER, Ian, GB
DALE, Adele, GB
VERNON, Bruce, GB
|
(73) |
Profactor Pharma Ltd.,
Roslin Biocentre, Roslin, Midlothian EH25 9PP,
GB
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Faktoriaus VIII ir von Vilebrando faktoriaus koekspresija |
CO-EXPRESSION OF FACTOR VIII AND VON WILLEBRAND FACTOR |
Payment date | Validity (years) | Amount | |
2024-03-12 | 11 | 289.00 EUR |
2025-03-18 |